Oral

Clostridium butyricum G protein-coupled receptor 120 Lactobacillus species Limosilactobacillus species endometritis metabolome microbiome resolvin D5

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2024
Historique:
received: 07 12 2023
accepted: 02 02 2024
medline: 7 3 2024
pubmed: 7 3 2024
entrez: 7 3 2024
Statut: epublish

Résumé

Endometritis occurs frequently in humans and animals, which can negatively affect fertility and cause preterm parturition syndrome. Orally administered

Identifiants

pubmed: 38450161
doi: 10.3389/fmicb.2024.1351899
pmc: PMC10915095
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1351899

Informations de copyright

Copyright © 2024 Hagihara, Ariyoshi, Eguchi, Oka, Takahashi, Kato, Shibata, Umemura, Mori, Miyazaki, Hirai, Asai, Mori and Mikamo.

Déclaration de conflit d'intérêts

TA, SE, KO, and MT are employees of Miyarisan Pharmaceutical Co., Ltd. HM received research funding and Ltd. consulting fee/honorarium from Miyarisan Pharmaceutical Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Mao Hagihara (M)

Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute, Japan.
Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Tadashi Ariyoshi (T)

R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.

Shuhei Eguchi (S)

R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.

Kentaro Oka (K)

R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.

Motomichi Takahashi (M)

R&D Division, Miyarisan Pharmaceutical Co., Ltd., Saitama, Japan.

Hideo Kato (H)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Yuichi Shibata (Y)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Takumi Umemura (T)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Takeshi Mori (T)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Narimi Miyazaki (N)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Jun Hirai (J)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Nobuhiro Asai (N)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Nobuaki Mori (N)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Hiroshige Mikamo (H)

Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute, Japan.

Classifications MeSH